[HTML][HTML] Factors affecting global adherence for the uptake of diabetic retinopathy screening: A systematic review and meta-analysis

M Rahmati, L Smith, L Boyer, G Fond, DK Yon… - American Journal of …, 2024 - Elsevier
Purpose: To evaluate diabetic retinopathy (DR) screening global adherence rate and the
association between sociodemographic and clinical variables and adherence rates to DR …

Prevalence of diabetic retinopathy in Tehran province: a population-based study

MA Javadi, M Katibeh, N Rafati, MH Dehghan… - BMC …, 2009 - Springer
Background To determine the prevalence and characteristics of diabetic retinopathy (DR)
among Iranian patients with diabetes. Methods Design: population-based cross-sectional …

[HTML][HTML] Diabetic retinopathy screening in patients with diabetes mellitus in primary care: Incentives and barriers to screening attendance

KND Van Eijk, JW Blom, J Gussekloo… - Diabetes research and …, 2012 - Elsevier
AIM: Although diabetic retinopathy (DR) screening is a basic component of diabetes care,
uptake of screening programs is less than optimal. Because attendance rates and reasons …

Awareness and practices regarding eye diseases among patients with diabetes: a cross sectional analysis of the CoDiab-VD cohort

L Konstantinidis, T Carron, E de Ancos, L Chinet… - BMC endocrine …, 2017 - Springer
Background The increasing prevalence of diabetes is leading to a rise of eye diseases,
augmenting the risk of sight-threatening complications. The aim of this study was to evaluate …

[HTML][HTML] Attenuation of diabetic retinopathy by enhanced inhibition of MMP-2 and MMP-9 using aspirin and minocycline in streptozotocin-diabetic rats

LK Bhatt, V Addepalli - American journal of translational research, 2010 - ncbi.nlm.nih.gov
Abstract Interruptions of Matrix Metalloproteinase-2 (MMP-2) and Matrix Metalloproteinase-9
(MMP-9) have been shown to reduce the ensuing threatening risk factors of vascular …

Protection of exendin-4 analogue in early experimental diabetic retinopathy

Y Zhang, Q Wang, J Zhang, X Lei, GT Xu… - Graefe's archive for clinical …, 2009 - Springer
Background Diabetic retinopathy (DR) is one of the leading causes of blindness, affecting
over 90% of diabetics. Exendin-4 (E4) is a potent and long-acting agonist of the glucagon …

The prevalence of and major risk factors associated with diabetic retinopathy in Gegharkunik province of Armenia: cross-sectional study

A Giloyan, T Harutyunyan, V Petrosyan - BMC ophthalmology, 2015 - Springer
Background Diabetic retinopathy (DR) is one of the leading causes of blindness in adults in
industrialized countries and the emerging cause of blindness in developing countries. The …

Screening for diabetic retinopathy and nephropathy in patients with diabetes: a nationwide survey in Korea

SH Byun, SH Ma, JK Jun, KW Jung, B Park - PLoS One, 2013 - journals.plos.org
This study was performed to identify factors associated with screening for diabetic
retinopathy and nephropathy. Data from the Korean National Health and Nutrition …

Factors associated with participation in a diabetic retinopathy screening program in a rural district in Bangladesh

FMA Islam, R Kawasaki, RP Finger - diabetes research and clinical practice, 2018 - Elsevier
Aim Diabetic retinopathy (DR) screening is one of the keys in successful diabetes care, but
the participation in DR screening is sub-optimal. This study aims to assess the factors …

The nonmydriatic fundus camera in diabetic retinopathy screening: a cost‐effective study with evaluation for future large‐scale application

G Scarpa, F Urban, S Vujosevic… - Journal of …, 2016 - Wiley Online Library
Aims. The study aimed to present the experience of a screening programme for early
detection of diabetic retinopathy (DR) using a nonmydriatic fundus camera, evaluating the …